Profil
Adam Schayowitz is currently Director at Terremoto Biosciences, Inc. and will be Executive VP, Head-Research & Development at Zymeworks, Inc. starting in 2026.
Formerly, Dr. Schayowitz was Director-Business Development at BioMarker Strategies LLC in 2012.
Education includes undergraduate studies at Hamilton College (New York), a doctorate from the University of Maryland conferred in 2008, and an MBA from The Johns Hopkins University.
Aktive Positionen von Adam Schayowitz
| Unternehmen | Position | Beginn |
|---|---|---|
| ZYMEWORKS INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.04.2026 |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Adam Schayowitz
| Unternehmen | Position | Ende |
|---|---|---|
BioMarker Strategies LLC
BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology Develops medicines for cancer | Corporate Officer/Principal | 01.11.2012 |
Ausbildung von Adam Schayowitz
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
BioMarker Strategies LLC
BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology Develops medicines for cancer | Health Technology |
Hamilton College (New York)
Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Zymeworks, Inc.
Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
















